
Pam Bondi reveals cancer diagnosis following dismissal from attorney general role
Pam Bondi reveals cancer diagnosis following dismissal from attorney general role
- Pam Bondi was diagnosed with thyroid cancer shortly after being removed as U.S. Attorney General.
- She is undergoing treatment and has accepted a role on the Presidential Council of Advisors on Science and Technology.
- Her appointment allows her to remain active in policy discussions while confronting her health challenges.
Story
In the United States, former Attorney General Pam Bondi has been diagnosed with thyroid cancer, announced shortly after her departure from the Department of Justice in April 2026. Bondi, who is 60 years old, shared that her diagnosis came following her removal from the attorney general position by President Donald Trump, which occurred amid growing criticism of her performance, particularly over her handling of the controversial Epstein files. Following her diagnosis, Bondi informed the public that she underwent surgery several weeks ago and is currently receiving treatment at home. Despite her health challenges, she is determined to continue her professional responsibilities, recently accepting a position on the Presidential Council of Advisors on Science and Technology (PCAST), which focuses on artificial intelligence policy. This move allows her to stay involved in significant policy issues while recovering. Pam Bondi's tenure as attorney general had been fraught with difficulties, including allegations of improper handling of politically sensitive investigations that drew ire from both political sides. This frustration culminated in her dismissal from the role. Her termination indicates a broader concern within the administration regarding portrayals of political adversaries and the management of politically sensitive cases. Despite the uncertainties surrounding her health, the prognosis for thyroid cancer is generally positive, with many forms of this cancer being treatable and often curable. Medical professionals highlight that thyroid cancer typically has a high survival rate when diagnosed early. Bondi's inclusion in the PCAST is viewed as a significant opportunity for her to leverage her experience in a critical area affecting U.S. leadership in science and technology. While navigating her health journey, she is expected to contribute to significant discussions and decisions relevant to AI in the country.